Newleos Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Neuroscience
Funding URL
View Funding Page
Funding Amount
$93,500,000
Company Info
Founders
Longwood Fund and seasoned leaders in CNS drug development
Market
CNS drug development
Location
Boston, MA, USA
Coinvestors
Goldman Sachs Alternatives, Novo Holdings A/S, Longwood Fund, DCVC Bio, Arkin Bio Capital
Company Description

Newleos Therapeutics is a clinical stage neuroscience company focused on developing oral small molecules targeting novel mechanisms for various CNS indications including generalized anxiety, social anxiety, substance use disorders, and cognitive impairment.

Links
Website
Back to HomeBack to Neuroscience DealsView Funding Announcement